Member Profile
TRI Cap Portfolio - Biopta Ltd
First Investment December 2008
TRI Cap is a new investor in Biopta Ltd, the human tissue-based contract research organisation. The £900,000 funding round also includes Braveheart Investment Group, Scottish Enterprise and Glasgow Caledonian University.
Biopta offers services using ethically donated residual human tissue from surgery as a test system for new pharmaceutical compounds. The investment will allow Biopta to expand the range of services it offers and to grow its team of scientists.
October 2010
TRI Cap has joined Braveheart in a further funding round into Biopta. The c£270,000 package also includes funds from Scottish Enterprise’s Scottish Co-investment Fund. Funds raised will be used to expand and market the TissueConnection service globally, to increase direct marketing activity, and to launch further new lines of business.
TRI Cap Contact: Gerry McGettigan
Number of TRI Cap Investors: 11
Biopta Contact: Elaine Ferguson
Garscube Estate, Glasgow
t: +44 (0)141 330 3831
e: info@biopta.com
www.biopta.com